NYC-WTC_000195068

NYC 9/11 Public Portal Document

ASBESTOS MEDITEXT ® - Medical Management Page 11 of 17

and latency time in malignant mesothelioma. Scand J Work Environ Health 1984; 10:293-298. 241. Murphy RLH, Ferris BG Jr, Burgess WA et al: Effects of low concentrations of asbestos. N Engl J Med 1971; 23:1271-1278. 242. Murray R: Asbestos: a chronology of its origins and health effects. Br J Ind Med 1990; 47:361- 365. 243. Muscat JE & Wynder EL: Cigarette smoking, asbestos expsure, and malignant mesothelioma. Cancer Res 1991; 51:2263-2267. 244. Nash DR, Fortson NG, McLarty JW et al: Serum protein concentrations and respiratory tract abnormalities following short-term exposure to amosite: a comparison between former asbestos workers and unexposed controls. J Toxicol Environ Health 1981; 7:733-74^1. 245. Nelson HH, Christiani DC, Wiencke JK et al: k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis. Cancer Res 1999; 59:4570-4573. 246. Neri S, Boraschi P, Antonelli A et al: Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos. Am J Ind Med 1996; 30:588-595. 247. Neuberger M & Kundi M: Individual asbestos exposure: smoking and mortality — a cohort study in the asbestos cement industry. Br J Ind Med 1990; 47:615-620. 248. Newhouse ML: Asbestos-related diseases. Practitioner 1983; 227:1399. 249. NIOSH: Pocket Guide to Chemical Hazards. National Institute for Occupational Safety and Health, Cincinnati, OH (CD-ROM Version). Micromedex, Inc, Englewood, CO (expires January 31,1999). 250. NIOSH: Pocket Guide to Chemical Hazards. National Institute for Occupational Safety and Health, Cincinnati, OH (Internet Version). Micromedex, Inc, Englewood, CO (expires 31 January 2001). 251. NTP: Lifetime carcinogenesis studies of chrysotile asbestos (CAS No 12001-29-5) in Syrian golden hamsters (feed studies). National Toxicology Program, Research Triangle Park, NC, Technical Report NTP TR 246, NIH Publication No 90-2502,1990. 252. Nyberg PW, Nordman SAS & Klockars MLG: Increased mineral dust-induced production of reactive oxygen species by blood monocytes from patients with malignant diseases. APMIS 1994; 102:765-770. 253. Oksa P, Klockars M, Karjalainen A et al: Progression of asbestosis predicts lung cancer. Chest 1998; 113:1517-1521. 254. Olofsson K & Mark J: Specificity of asbestos-induced chromosomal aberrations in short-term cultured human mesothelial cells. Cancer Genet Cytogenet 1989; 41:33-39. 255. Olsson H & Brandt L: Asbestos exposure and non-Hodgkin's lymphoma. Lancet 1983; 1:588. 256. Osgood C & Sterling D: Chrysotile and amosite asbestos induce germ-line aneuploidy in Drosophila. MutatRes 1991; 261:9-13. 257. OSHA: 29 CFR 1910.1000; Air contaminants. Department of Labor, Occupational Safety and Health Administration, Washington, DC, July 1, 1997a. 258. OSHA: 29 CFR 1910.119; Appendix A, List of Highly Hazardous Chemicals, Toxics and Reactives (Mandatory). Department of Labor, Occupational Safety and Health Administration, Washington, DC, July 1, 1997. 259. Oshimura M et al: Cancer Res 1984; 44:5017-5022. 260. Otte KE, Sigsgaard TI & Kjaerulff J: Malignant mesothelioma: clustering in a family producing asbestos cement in their home. Br J Ind Med 1990; 47:10-13. 261. Pames SM: Asbestos and cancer of the larynx: is there a relationship? Laryngoscope 1990; 100:254-261. 262. Pelin-Enlund K, Husgafvel-Pursiainen K, Tammilehto L et al: Asbestos-related malignant mesothelioma: growth, cytology, tumorigenicity and consistent chromosome findings in cell

http ://ww w. tomescps .com/DAT A/TM/TM3 56-c. htm 1/4/2002

CITY_21MC100_011105094

NYC-WTC_000195112